Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04045613
Title Derazantinib and Atezolizumab in Patients With Urothelial Cancer (FIDES-02)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Basilea Pharmaceutica
Indications

bladder urothelial carcinoma

Therapies

Derazantinib

Atezolizumab + Derazantinib

Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST